Lyell Immunopharma Stock (NASDAQ: LYEL) stock price, news, charts, stock research, profile.
You can purchase shares of Lyell Immunopharma (NASDAQ:LYEL) through any online brokerage.
Other companies in Lyell Immunopharma’s space includes: Voyager Therapeutics (NASDAQ:VYGR), Sage Therapeutics (NASDAQ:SAGE), Fate Therapeutics (NASDAQ:FATE), Anika Therapeutics (NASDAQ:ANIK) and aTyr Pharma (NASDAQ:ATYR).
Lyell Immunopharma has a consensus price target of $2.75.
The stock price for Lyell Immunopharma (NASDAQ: LYEL) is $0.9199 last updated November 21, 2024 at 5:08 PM EST.
There are no upcoming dividends for Lyell Immunopharma.
Lyell Immunopharma’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Lyell Immunopharma.
Lyell Immunopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.